Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 3,669 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Mayo Clinic Clear all

Conditions: Healthy
Interventions: Pulse wave velocity measurement Photoplethysmogram, tonometer; Device
Lead sponsor: Nonin Medical, Inc; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Lifestyle Factors, Headache Disorders
Interventions: Lifestyle Behavior Protocol, Sham Behavior Protocol; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Opioid Withdrawal
Interventions: Lofexidine Oral Tablet; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Refractory Plasma Cell Myeloma
Interventions: Dexamethasone, Elotuzumab, Pomalidomide; Drug · Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Omega-3 Fatty Acids, Pediatric Bipolar Disorder, Adolescent Bipolar Disorder, Magnetic Resonance Spectroscopy Imaging
Interventions: Omega-3 Fatty Acid, Placebo; Dietary Supplement · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 18 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Myeloma
Interventions: 5-Carbon C 13-labeled Glutamine, Biospecimen Collection, Uniformly-labeled [13C]glucose; Other · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cirrhosis, Liver, Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 852 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 14
States / cities: Phoenix, Arizona • Redwood City, California • San Diego, California + 8 more

Conditions: Pulmonary Lesions, Pulmonary Nodules, Pulmonary Mass
Interventions: Standard FB with fluoroscopy, R-EBUS with ultrathin bronchoscope; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 22 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Gainesville, Florida • Baltimore, Maryland + 2 more

Conditions: Airway Complication of Anesthesia, Difficult or Failed Intubation
Interventions: Airway and Ventilation; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cancer, Tumor
Interventions: MRI guided procedure software evaluation; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Acupressure Therapy, Acupressure Therapy - placebo, Acupressure Therapy - self-administered, Health Promotion and Education, Survey Administration; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Muscular Weakness
Interventions: Exercise; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 36 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity
Interventions: Phentermine-Topiramate, Liraglutide, Naltrexone/bupropion, Phentermine; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy
Interventions: TopSpin360; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Plasma Cell Myeloma
Interventions: Autologous Hematopoietic Stem Cell Transplantation, Daratumumab, Lenalidomide; Procedure · Biological · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Interventions: Wellness Program, Wellness Coaching; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Congenital Disorders of Glycosylation
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 12
States / cities: San Diego, California • Aurora, Colorado • Jacksonville, Florida + 9 more

Conditions: Inflammatory Bowel Diseases
Interventions: Blood Draw, Urine Collection, Stool Collection; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2065
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Germ Cell Tumor, Recurrent Primary Peritoneal Carcinoma, Undifferentiated Ovarian Carcinoma
Interventions: Everolimus, Laboratory Biomarker Analysis, Letrozole; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Gastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II, Functional Disorder of Gastrointestinal Tract, Gastro-Intestinal Disorder
Interventions: Not listed
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Scottsdale, Arizona • Louisville, Kentucky • Boston, Massachusetts + 3 more

Conditions: Type1diabetes
Interventions: BKR-017; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 20 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cancer
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 9
States / cities: Orange, California • Hartford, Connecticut • Wilmington, Delaware + 6 more

Conditions: Contact Dermatitis
Interventions: AI algorithm to evaluate photographs of skin test patch regions, Allergen Patch; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Stress, Psychological
Interventions: Manualized Therapy, Control Group; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Search by objective public record fields.

Measurement of Pulse Wave Velocity

Determining the Utility of a Behavioral Intervention in Chronic Migraine

Lofexidine for Adults Undergoing Lumbar Spine Surgery

Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma

Omega 3 Fatty Acid Trial

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )

Supraglottic Airway Needed To Achieve Ventilation

Prospective Use of Philips iSuite for Interventional Procedures

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

Enhancing Gluteus Maximus Recruitment

Individualized Obesity Pharmacotherapy

A Study of TopSpin360 Training Device

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

IBD and Women's Health Wellness Program

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Mayo Clinic IBD Biobank

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Gastroparesis Registry 4

Butyrate Adjuvant Therapy for Type 1 Diabetes

Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

DermAI to Evaluate Human Factor of Testing

Fostering Resilience in Physician Moms